Investments
91Portfolio Exits
14Funds
3About MB Venture Partners
MB Venture Partners is a stage agnostic venture capital firm. Generally, the firm seeks to invest in seed and early stage financing but will selectively look at later stage opportunities. MB Venture Partners' primarily invests in biotech and medical devices.
Latest MB Venture Partners News
Nov 13, 2023
Stevenson was co-founder and managing partner of MB Venture Partners. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it’s been delivered there. If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com. Copyright PEI Media Share with other subscribers Cancel
MB Venture Partners Investments
91 Investments
MB Venture Partners has made 91 investments. Their latest investment was in Cast21 as part of their Unattributed VC on August 8, 2021.
MB Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/13/2021 | Unattributed VC | Cast21 | $3.17M | No | 2 | |
7/6/2021 | Unattributed VC | CrossRoads Extremity Systems | $3.74M | No | 3 | |
12/23/2019 | Series B | Lineus Medical | $1.25M | No | 2 | |
11/1/2018 | Unattributed VC | |||||
6/15/2018 | Series A - III |
Date | 8/13/2021 | 7/6/2021 | 12/23/2019 | 11/1/2018 | 6/15/2018 |
|---|---|---|---|---|---|
Round | Unattributed VC | Unattributed VC | Series B | Unattributed VC | Series A - III |
Company | Cast21 | CrossRoads Extremity Systems | Lineus Medical | ||
Amount | $3.17M | $3.74M | $1.25M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 2 | 3 | 2 |
MB Venture Partners Portfolio Exits
14 Portfolio Exits
MB Venture Partners has 14 portfolio exits. Their latest portfolio exit was Statera Spine on August 27, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/27/2020 | Acquired | 3 | |||
9/24/2018 | Acquired | 1 | |||
1/4/2018 | Acquired | 1 | |||
Date | 8/27/2020 | 9/24/2018 | 1/4/2018 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 3 | 1 | 1 |
MB Venture Partners Fund History
3 Fund Histories
MB Venture Partners has 3 funds, including Memphis Biomed Ventures III LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
11/16/2011 | Memphis Biomed Ventures III LP | Multi-Stage Venture Capital | Open | $22M | 1 |
10/2/2006 | Memphis Biomed Ventures II | ||||
10/1/2002 | Memphis Biomed Ventures I LP |
Closing Date | 11/16/2011 | 10/2/2006 | 10/1/2002 |
|---|---|---|---|
Fund | Memphis Biomed Ventures III LP | Memphis Biomed Ventures II | Memphis Biomed Ventures I LP |
Fund Type | Multi-Stage Venture Capital | ||
Status | Open | ||
Amount | $22M | ||
Sources | 1 |
MB Venture Partners Team
2 Team Members
MB Venture Partners has 2 team members, including current Founder, Managing Partner, Gary D. Stevenson.
Name | Work History | Title | Status |
|---|---|---|---|
Gary D. Stevenson | Morgan Keegan Ventures, A.G. Edwards, Abbott, and Arthur Andersen | Founder, Managing Partner | Current |
Name | Gary D. Stevenson | |
|---|---|---|
Work History | Morgan Keegan Ventures, A.G. Edwards, Abbott, and Arthur Andersen | |
Title | Founder, Managing Partner | |
Status | Current |
Loading...